PremiumCompany AnnouncementsHBM Holdings Subsidiary Partners with Visterra for Biotherapeutic Advancements HBM Holdings Announces Successful AGM Resolutions HBM Holdings Appoints Dr. Ian Yi Liu as Joint Company Secretary PremiumCompany AnnouncementsHBM Holdings Announces 2025 Annual General Meeting Agenda HBM Holdings Announces HK$200 Million Share Repurchase Plan HBM Holdings Completes Subscription Shares Issuance to AstraZeneca PremiumCompany AnnouncementsHBM Holdings Enters Strategic Collaboration for Novel CRH Therapies HBM Holdings Reports Strong 2024 Business Performance and Share Repurchase HBM Holdings Ltd. Strengthens Market Position with Strategic Share Repurchase and Collaborations